The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2023
DOI: 10.1007/s10815-023-02902-z
|View full text |Cite
|
Sign up to set email alerts
|

Chronic endometritis: screening, treatment, and pregnancy outcomes in an academic fertility center

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 20 publications
0
0
0
Order By: Relevance
“…CE is attracting interest because of its association with female infertility, including unexplained etiology (10–57%) [ 9 , 10 , 11 ], endometriosis (5–53%) [ 12 , 13 , 14 , 15 , 16 ], repeated implantation failure in an in vitro fertilization–embryo transfer program (7–31%) [ 7 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 ], unexplained recurrent pregnancy loss (9–13%) [ 27 , 28 , 29 , 30 , 31 , 32 ], fallopian tubal infertility (45.9% of hydrosalpinx, 14.3% of peritubal adhesion, and 13.0% of tubal occlusion) [ 33 , 34 , 35 , 36 ], polycystic ovarian syndrome (32–42%) [ 37 ], endometrial polyps (86%) [ 38 , 39 , 40 , 41 , 42 , 43 ], submucosal uterine fibroids (69%) [ 44 ], septate uterus (46%) [ 44 ], intrauterine adhesion/Asherman syndrome (28–79%) [ 44 , 45 , 46 , 47 ], and cesarean scar disorder (28–66%) [ 48 , 49 ]. The European Society of Human Reproduction and Embryology Working Group recently published Good Practice Recommendations on Recurrent Implantation Failure 2023, a document in which assessment for CE can be considered for infertile women suffering from repeated implantation failure following in vitro fertilization–embryo transfer programs and tre...…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…CE is attracting interest because of its association with female infertility, including unexplained etiology (10–57%) [ 9 , 10 , 11 ], endometriosis (5–53%) [ 12 , 13 , 14 , 15 , 16 ], repeated implantation failure in an in vitro fertilization–embryo transfer program (7–31%) [ 7 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 ], unexplained recurrent pregnancy loss (9–13%) [ 27 , 28 , 29 , 30 , 31 , 32 ], fallopian tubal infertility (45.9% of hydrosalpinx, 14.3% of peritubal adhesion, and 13.0% of tubal occlusion) [ 33 , 34 , 35 , 36 ], polycystic ovarian syndrome (32–42%) [ 37 ], endometrial polyps (86%) [ 38 , 39 , 40 , 41 , 42 , 43 ], submucosal uterine fibroids (69%) [ 44 ], septate uterus (46%) [ 44 ], intrauterine adhesion/Asherman syndrome (28–79%) [ 44 , 45 , 46 , 47 ], and cesarean scar disorder (28–66%) [ 48 , 49 ]. The European Society of Human Reproduction and Embryology Working Group recently published Good Practice Recommendations on Recurrent Implantation Failure 2023, a document in which assessment for CE can be considered for infertile women suffering from repeated implantation failure following in vitro fertilization–embryo transfer programs and tre...…”
Section: Introductionmentioning
confidence: 99%
“…CE is attracting interest because of its association with female infertility, including unexplained etiology (10-57%) [9][10][11], endometriosis (5-53%) [12][13][14][15][16], repeated implantation failure in an in vitro fertilization-embryo transfer program (7-31%) [7,[17][18][19][20][21][22][23][24][25][26], unexplained recurrent pregnancy loss (9-13%) [27][28][29][30][31][32], fallopian tubal infertility (45.9% of hydrosalpinx, 14.3% of peritubal adhesion, and 13.0% of tubal occlusion) [33][34][35][36], polycystic ovarian syndrome (32-42%) [37], endometrial polyps (86%) [38][39][40][41][42][43], submucosal uterine fibroids (69%) [44], septate uterus (46%) [44], intrauterine adhesion/Asherman syndrome (28-79%) [44][45][46][47], and cesarean scar disorder (28-66%) [48,49]. The European Society of Human Reproduction and Embryology Working Group recently published Good Practice Recommendations on R...…”
Section: Introductionmentioning
confidence: 99%